RaQualia Pharma, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -16.93% vs 48.84% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -4,240.38% vs 93.34% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "802.00",
          "val2": "965.40",
          "chgp": "-16.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-48.80",
          "val2": "211.00",
          "chgp": "-123.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.00",
          "val2": "15.00",
          "chgp": "6.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.50",
          "val2": "20.20",
          "chgp": "-156.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-225.70",
          "val2": "-5.20",
          "chgp": "-4,240.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-199.70%",
          "val2": "96.40%",
          "chgp": "-29.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 155.17% vs -52.92% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,980.00",
          "val2": "3,107.60",
          "chgp": "28.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "971.90",
          "val2": "188.30",
          "chgp": "416.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "61.10",
          "val2": "184.10",
          "chgp": "-66.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "26.20",
          "val2": "-23.50",
          "chgp": "211.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "273.10",
          "val2": "-495.00",
          "chgp": "155.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.50%",
          "val2": "-68.70%",
          "chgp": "19.02%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

802.00

965.40

-16.93%

Operating Profit (PBDIT) excl Other Income

-48.80

211.00

-123.13%

Interest

16.00

15.00

6.67%

Exceptional Items

-11.50

20.20

-156.93%

Consolidate Net Profit

-225.70

-5.20

-4,240.38%

Operating Profit Margin (Excl OI)

-199.70%

96.40%

-29.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -16.93% vs 48.84% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -4,240.38% vs 93.34% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,980.00

3,107.60

28.07%

Operating Profit (PBDIT) excl Other Income

971.90

188.30

416.14%

Interest

61.10

184.10

-66.81%

Exceptional Items

26.20

-23.50

211.49%

Consolidate Net Profit

273.10

-495.00

155.17%

Operating Profit Margin (Excl OI)

121.50%

-68.70%

19.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 155.17% vs -52.92% in Dec 2024

All Annual Results